Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
1. 系统已在2025-06-11 15:59:12对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jaad.2024.09.031
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0190962224028871
其他信息:
出版社: Elsevier BV
作者: Kexiang Yan; Fuqiu Li; Xiaodong Bi; Ling Han; Zhenghua Zhang; Rixin Chen; Yuye Li; Litao Zhang; Xiaohua Wang; Linfeng Li; Jianyun Lu; Ai'e Xu; Sen Yang; Yan Lu; Jianfang Sun; Zhiming Li; Xiaohong Zhu; Meiying Jiang; Siping Zhang; Wenqing Wang; Yanling Li; Zudong Meng; Hongyi Li; Kuanhou Mou; Xiuping Han; Shanshan Li; Aijun Chen; Xin Li; Donghua Liu; Chunlei Zhang; Chao Ji; Yu Wang; Hao Cheng; Xiaojing Cui; Xiaoyan Yao; Xiaoyan Bai; Guangchao Dong; Jinhua Xu
